7 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18334820 | TISSUE-SPECIFIC ANTIGENS FOR CANCER IMMUNOTHERAPY | ROONEY, NORA MAUREEN | 1641 | Non-Final OA | Jun 14, 2023 |
| 18311155 | NEOANTIGENS AND METHODS OF THEIR USE | ALLEN, MICHAEL D | 1671 | Non-Final OA | May 02, 2023 |
| 18007024 | T CELL MANUFACTURING COMPOSITIONS AND METHODS | JUEDES, AMY E | 1644 | Non-Final OA | Jan 26, 2023 |
| 17495571 | METHOD AND SYSTEMS FOR PREDICTION OF HLA CLASS II-SPECIFIC EPITOPES AND CHARACTERIZATION OF CD4+ T CELLS | SABOUR, GHAZAL | 1686 | Non-Final OA | Oct 06, 2021 |
| 17599468 | COMPOSITIONS AND METHODS FOR PREPARING T CELL COMPOSITIONS AND USES THEREOF | FAUST, AMBER KATHLEEN | 1643 | Final Rejection | Sep 28, 2021 |
| 17481781 | CORONAVIRUS VACCINES AND METHODS OF USE | STUART, CAREY ALEXANDER MC | 1671 | Final Rejection | Sep 22, 2021 |
| 17253922 | NEOANTIGENS AND USES THEREOF | SANG, HONG | 1646 | Non-Final OA | Dec 18, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial